Teladoc Health Inc (NYSE: TDOC) on Monday, plunged -3.69% from the previous trading day, before settling in for the closing price of $9.21. Within the past 52 weeks, TDOC’s price has moved between $6.76 and $22.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 48.49% over the past five years. The company achieved an average annual earnings per share of -334.56%. With a float of $169.49 million, this company’s outstanding shares have now reached $172.17 million.
Let’s look at the performance matrix of the company that is accounted for 5600 employees. In terms of profitability, gross margin is 63.31%, operating margin of -9.96%, and the pretax margin is -37.49%.
Teladoc Health Inc (TDOC) Insider and Institutional Ownership
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Teladoc Health Inc is 1.56%, while institutional ownership is 77.13%. The most recent insider transaction that took place on Nov 04 ’24, was worth 52,845. Before that another transaction happened on Nov 04 ’24, when Company’s Former Officer proposed sale 160,278 for $8.87, making the entire transaction worth $1,421,691.
Teladoc Health Inc (TDOC) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.17 earnings per share (EPS) for the period topping the consensus outlook (set at -0.21) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -334.56% per share during the next fiscal year.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
Teladoc Health Inc (TDOC) is currently performing well based on its current performance indicators. A quick ratio of 1.65 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.60. Likewise, its price to free cash flow for the trailing twelve months is 4.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.78, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of Teladoc Health Inc (TDOC)
Teladoc Health Inc (NYSE: TDOC) saw its 5-day average volume 8.38 million, a positive change from its year-to-date volume of 5.5 million. As of the previous 9 days, the stock’s Stochastic %D was 39.20%. Additionally, its Average True Range was 0.58.
During the past 100 days, Teladoc Health Inc’s (TDOC) raw stochastic average was set at 51.59%, which indicates a significant increase from 34.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.33% in the past 14 days, which was lower than the 56.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.51, while its 200-day Moving Average is $11.79. Nevertheless, the first resistance level for the watch stands at $9.28 in the near term. At $9.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.18. If the price goes on to break the first support level at $8.38, it is likely to go to the next support level at $7.90. The third support level lies at $7.48 if the price breaches the second support level.
Teladoc Health Inc (NYSE: TDOC) Key Stats
Market capitalization of the company is 1.56 billion based on 171,218K outstanding shares. Right now, sales total 2,602 M and income totals -220,370 K. The company made 642,440 K in profit during its latest quarter, and -837,670 K in sales during its previous quarter.
